Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Current Size And Growth Outlook For The mRNA Therapeutics Market?

The market for mRNA therapeutics has experienced a steady expansion over the past few years. The market, which stands at $34.76 billion in 2024, is anticipated to reach $35.9 billion in 2025, with a compound annual growth rate (CAGR) of 3.3%. Factors such as increased financial backing for the development of effective drugs and vaccines, the enlargement of government initiatives promoting RNA-based treatments, greater understanding of uncommon genetic diseases, and an increase in the volume of clinical trials have contributed to its growth during the historical period.

Forecasts suggest a consistent expansion in the mRNA therapeutics market over the coming years, projecting a growth to $41.08 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 3.4%. The predicted growth during this period can be associated with increasing instances of infectious diseases, the rising patient volume in hospitals and clinics, the broadening uses of mRNA therapeutics, the escalating demand for personalized and precision medicine, favorable governmental regulations, and expedited approval routes. Noteworthy trends anticipated for the forecast period are improvements in mRNA delivery technologies, swift progression and adoption of mRNA vaccines, the emergence of self-amplifying mRNA (saRNA) platforms, the scalability and adaptability of mRNA manufacturing processes, and the emergence of new mRNA modifications.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp

What Growth-Enabling Forces Are Impacting The mRNA Therapeutics Market?

The rise in persistent and communicable diseases is projected to stimulate the mRNA therapeutics market’s growth. These diseases, which include tuberculosis, HIV/AIDS, and hepatitis, linger for long periods and can be passed from person to person. The increasing instances of these diseases, fueled by greater global travel and insufficient healthcare systems, foster their spread and obstruct effective treatment. mRNA therapeutics play a role in combatting these diseases by facilitating fast production of proteins to enhance immune responses, thus hastening the creation of vaccines and treatments. For example, GOV.UK, a government website in the UK, recorded in October 2023 that in 2022, a total of 94,397 individuals in England were diagnosed and treated for HIV, showing a 3% rise from the 91,368 cases in 2021. This escalating prevalence of stubborn and communicable diseases is thus propelling the expansion of the mRNA therapeutics market.

Which Segments Define The Structure Of The mRNA Therapeutics Market?

The mrna therapeutics market covered in this report is segmented –

1) By Product: Vaccines, Drugs

2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications

3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses

Subsegments:

1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines

2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs

What Strategic Shifts And Innovations Are Influencing The mRNA Therapeutics Market?

Leading firms in the mRNA therapeutics market are investing in novel solutions, such as mRNA-based booster vaccines, to improve immunity against constantly changing viral strains. The term mRNA-based booster vaccine refers to a vaccine using messenger RNA technology that boosts and sustains immunity against a particular pathogen, usually subsequent to the initial vaccination sequence. As an example, Gennova Biopharmaceuticals Ltd., an Indian pharmaceutical firm, introduced India’s inaugural indigenous mRNA-based Omicron-specific booster vaccine, known as GEMCOVAC-OM, in June 2023. This specific variant vaccine is designed to provoke the requisite immune response against the Omicron variant of SARS-CoV-2. GEMCOVAC-OM is heat-resistant, does not necessitate ultra-cold storage infrastructure, this is administrable without needle injection via a needleless device system, making it accessible for deployment in remote facilities in India. Clinical tests showed that the vaccine elicited higher immune responses than other vaccines, underscoring the importance of variant-focused vaccines to generate the necessary immune reactions.

Who Are The Primary Market Leaders In The mRNA Therapeutics Market?

Major companies operating in the mRNA therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

What Regional Factors Are Accelerating Growth In The mRNA Therapeutics Market?

North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=17205&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model